YD Bio Ltd
YDES
10 hedge funds and large institutions have $1.73M invested in YD Bio Ltd in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.05% less ownership
Funds ownership: 0.25% → 0.2% (-0.05%)
49% less capital invested
Capital invested by funds: $3.42M → $1.73M (-$1.69M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$156K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$71.4K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$34K |
| 4 |
Citigroup
New York
|
+$23.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$67 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$619K |
| 2 |
CS
Clear Street
New York
|
-$146K |
| 3 |
Morgan Stanley
New York
|
-$134K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$42.2K |
| 5 |
CCMW
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
|
-$33.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $711K | +$71.4K | +5,292 | +10% |
|
2
Cerity Partners
New York
| $395K | – | – | – |
|
|
CCMW
3
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
| $336K | -$33.1K | -2,450 | -8% |
|
|
4
Citadel Advisors
Miami,
Florida
| $141K | +$156K | +11,549 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $87.7K | -$42.2K | -3,124 | -30% |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $30.7K | +$34K | +2,516 | New |
|
|
7
Citigroup
New York
| $20.8K | +$23.1K | +1,709 | New |
|
|
8
Morgan Stanley
New York
| $3.65K | -$134K | -9,958 | -97% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $61 | +$67 | +5 | New |
|
10
Fidelity Investments
Boston,
Massachusetts
| $12 | – | – | – |
|
|
HF
11
HRT Financial
New York
| – | -$619K | -31,819 | Closed |
|
|
CS
12
Clear Street
New York
| – | -$146K | -7,500 | Closed |
|
13
BNP Paribas Financial Markets
Paris,
France
| – | -$1.75K | -90 | Closed |
|
14
Barclays
London,
United Kingdom
| – | -$1.13K | -58 | Closed |
|
YDES Hedge Fund Activity: Q4 2025 in Review
10 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in YD Bio Ltd (YDES) for Q4 2025, worth a combined $1.73M — down 49% from $3.42M a quarter earlier.
Fund positioning in YDES was balanced in Q4 2025: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $156K. The largest seller was HRT Financial, exiting entirely with an estimated $619K sold.
- 10 institutional investors held YD Bio Ltd (YDES) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $1.73M of YD Bio Ltd stock for Q4 2025, down 49% quarter-over-quarter.
- 4 funds opened new YD Bio Ltd positions in Q4 2025 and 4 closed out, a net change of 0 holders.
- The largest YD Bio Ltd buyer in Q4 2025 was Citadel Advisors, an estimated $156K added.
- The largest YD Bio Ltd seller in Q4 2025 was HRT Financial, an estimated $619K sold.
Based on aggregated 13F filings for Q4 2025.